CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $0 | – | 45 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 45 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 45 | -94.2% | 0.00% | – |
Q3 2015 | $6,000 | -60.0% | 776 | -52.8% | 0.00% | – |
Q2 2015 | $15,000 | 0.0% | 1,645 | 0.0% | 0.00% | – |
Q1 2015 | $15,000 | – | 1,645 | +3555.6% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 45 | -99.6% | 0.00% | – |
Q3 2014 | $107,000 | -61.4% | 12,011 | -65.9% | 0.00% | – |
Q2 2014 | $277,000 | +20.4% | 35,265 | +21.3% | 0.00% | – |
Q1 2014 | $230,000 | – | 29,065 | +44615.4% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 65 | -75.5% | 0.00% | – |
Q3 2013 | $1,000 | – | 265 | +1225.0% | 0.00% | – |
Q2 2013 | $0 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |